Trend Analysis of Sexually Transmitted Infection Treatments in Korea
Purpose The revision of the 2023 Guidelines for the Treatment of Sexually Transmitted Infections (STIs) has been released. Hence, it is necessary to analyze the current status of STI treatments in Korea. Materials and Methods A questionnaire was distributed to urologists and gynecologists from Decem...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Association of Urogenital Tract Infection and Inflammation
2024-08-01
|
| Series: | Urogenital Tract Infection |
| Subjects: | |
| Online Access: | http://euti.org/upload/pdf/UTI019-02-01.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849247497962127360 |
|---|---|
| author | Soeon Park Byung Kyu Han Sangrak Bae Seung-Ju Lee Jin Bong Choi |
| author_facet | Soeon Park Byung Kyu Han Sangrak Bae Seung-Ju Lee Jin Bong Choi |
| author_sort | Soeon Park |
| collection | DOAJ |
| description | Purpose The revision of the 2023 Guidelines for the Treatment of Sexually Transmitted Infections (STIs) has been released. Hence, it is necessary to analyze the current status of STI treatments in Korea. Materials and Methods A questionnaire was distributed to urologists and gynecologists from December 2022 to January 2023 through an online survey program. Three hundred and forty-one urologists and 302 gynecologists responded to the questionnaire. Results For Neisseria gonorrhea treatment, ceftriaxone 500 mg and 100 mg of doxycycline twice daily for seven days were most preferred by urologists (22.58%). The treatment most preferred by gynecologists (15.23%) was 500 mg of ceftriaxone and 1 g of azithromycin in a single dose. Both urologists and gynecologists generally treat Chlamydia trachomatis according to the treatment guidelines. For treating Mycoplasma genitalium, 29.03% of urologists preferred administering azithro-mycin at 500 mg once daily, followed by 250 mg for four days. In contrast, 33.11% of gynecologists preferred doxycycline 100 mg twice daily for seven days. Conclusions Most urologists and gynecologists followed the treatments recommended in the 2nd edition of the STI treatment guidelines, revised in 2016. As many treatment regimens have changed because of the recent increase in antibiotic-resistant STIs, there is a need to encourage them to follow the new treatment guidelines. |
| format | Article |
| id | doaj-art-92a814c492394e25be6aaedb1120df3e |
| institution | Kabale University |
| issn | 2465-8243 2465-8510 |
| language | English |
| publishDate | 2024-08-01 |
| publisher | Korean Association of Urogenital Tract Infection and Inflammation |
| record_format | Article |
| series | Urogenital Tract Infection |
| spelling | doaj-art-92a814c492394e25be6aaedb1120df3e2025-08-20T03:58:11ZengKorean Association of Urogenital Tract Infection and InflammationUrogenital Tract Infection2465-82432465-85102024-08-01192253010.14777/uti.2024.19.2.25416Trend Analysis of Sexually Transmitted Infection Treatments in KoreaSoeon Park0Byung Kyu Han1Sangrak Bae2Seung-Ju Lee3Jin Bong Choi4Department of Urology, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaDepartment of Urology, Perfect Urology Clinic, Seoul, KoreaDepartment of Urology, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaDepartment of Urology, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaDepartment of Urology, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaPurpose The revision of the 2023 Guidelines for the Treatment of Sexually Transmitted Infections (STIs) has been released. Hence, it is necessary to analyze the current status of STI treatments in Korea. Materials and Methods A questionnaire was distributed to urologists and gynecologists from December 2022 to January 2023 through an online survey program. Three hundred and forty-one urologists and 302 gynecologists responded to the questionnaire. Results For Neisseria gonorrhea treatment, ceftriaxone 500 mg and 100 mg of doxycycline twice daily for seven days were most preferred by urologists (22.58%). The treatment most preferred by gynecologists (15.23%) was 500 mg of ceftriaxone and 1 g of azithromycin in a single dose. Both urologists and gynecologists generally treat Chlamydia trachomatis according to the treatment guidelines. For treating Mycoplasma genitalium, 29.03% of urologists preferred administering azithro-mycin at 500 mg once daily, followed by 250 mg for four days. In contrast, 33.11% of gynecologists preferred doxycycline 100 mg twice daily for seven days. Conclusions Most urologists and gynecologists followed the treatments recommended in the 2nd edition of the STI treatment guidelines, revised in 2016. As many treatment regimens have changed because of the recent increase in antibiotic-resistant STIs, there is a need to encourage them to follow the new treatment guidelines.http://euti.org/upload/pdf/UTI019-02-01.pdfguidelinesexually transmitted infectionsquestionnairetrends |
| spellingShingle | Soeon Park Byung Kyu Han Sangrak Bae Seung-Ju Lee Jin Bong Choi Trend Analysis of Sexually Transmitted Infection Treatments in Korea Urogenital Tract Infection guideline sexually transmitted infections questionnaire trends |
| title | Trend Analysis of Sexually Transmitted Infection Treatments in Korea |
| title_full | Trend Analysis of Sexually Transmitted Infection Treatments in Korea |
| title_fullStr | Trend Analysis of Sexually Transmitted Infection Treatments in Korea |
| title_full_unstemmed | Trend Analysis of Sexually Transmitted Infection Treatments in Korea |
| title_short | Trend Analysis of Sexually Transmitted Infection Treatments in Korea |
| title_sort | trend analysis of sexually transmitted infection treatments in korea |
| topic | guideline sexually transmitted infections questionnaire trends |
| url | http://euti.org/upload/pdf/UTI019-02-01.pdf |
| work_keys_str_mv | AT soeonpark trendanalysisofsexuallytransmittedinfectiontreatmentsinkorea AT byungkyuhan trendanalysisofsexuallytransmittedinfectiontreatmentsinkorea AT sangrakbae trendanalysisofsexuallytransmittedinfectiontreatmentsinkorea AT seungjulee trendanalysisofsexuallytransmittedinfectiontreatmentsinkorea AT jinbongchoi trendanalysisofsexuallytransmittedinfectiontreatmentsinkorea |